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S59ABSTRACTS / Biochimica et Biophysica Acta 1777 (2008) S2–S111observed fragmentation of mitochondrial reticulum, oxidative phos-
phorylation disruption, permeability transition induction, that can
lead to kidney cell loss. We also explored the defensive mechanisms
such as GSK-3 inhibition, hypoxic preconditioning, mitochondria-
targeted antioxidant use which prevented mitochondria damaging
and increased cell survival. Partially these effects involve action of
nonpathologic quantities of ROS and NO. According to our data during
ARF mitochondria are the source, sensors and targets for ROS and NO.
Delicate regulation of ROS- and NO-production and utilization is of
critical importance to determine the cell fate, which can lead to kidney
malfunctioning.
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Neutrophils play an essential role in the body's innate defence
against pathogens and are one of the primary mediators of the
inﬂammatory response. Neutrophils use a wide range of microbicidal
products, such as oxidants, microbicidal peptides and lytic enzymes to
kill invadingpathogens. The generation ofmicrobicidal oxidants results
from the activation of a multiprotein enzyme complex known as the
NADPH oxidase, which catalyses the formation of superoxide anion
O2y−. The complex is composed of 4 cytosolic subunits (p40phox,
p47phox, p67phox, Rac) and two membrane proteins (gp91phox,
p22phox). The aim of this work is to clarify the binding of the primary
electron donor NADPH on this complex. Two hypotheses have been
proposed, either a binding of the nucleotide on a cytosolic component
called p67phox or on the membrane ﬂavocytochrome b558. The
availabilityas a recombinant protein of p67phoxhas alloweda thorough
studyon this latest. Severalmethods have been used suchas tryptophan
quenching, inhibitor analogs and centrifugal sedimentation. None of
these techniques has revealed binding of NADPH on p67phox, in
opposite to the gp91phox. In conclusion, as expected, the nucleotide
binds on the ﬂavocytochrome b558 close to FAD for an efﬁcient electron
transfer, the role of p67phox would be to change the afﬁnity of NADPH
to regulate the activity of the complex NADPH oxidase.
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The nicotinamide adenine dinucleotide phosphate (NAD(P)H)
oxidase is an essential multiprotein complex present in phagocytic
cells of the innate immune system having for function, in response to a
bacterial infection, to generate superoxide from a single electron
reduction of molecular oxygen using as electron donor NADPH. The
catalytic component of this complex is a membrane bound ﬂavocy-
tochrome b, referred to as ﬂavocytochrome b558 (cyt b558) which
consists of a heterodimer of two non-covalently linked glycosylated
proteins p22phox and gp91phox. The biochemical studies indicate that
in addition to the two hemes, cytb558 contains a functional FADprosthetic group. There are, at the moment, neither direct structural
data of cytb558, nor on theway it binds its redox components. Various
studies allowed to propose structural models but which remain still
hypothetical. The limiting factor for functional and structural studies
is the lack of sufﬁcient amounts of the cytb558 in stable, pure and
homogenous form. Therefore, we are focusing our efforts in producing
the membrane heterodimer by designing an engineered efﬁcient
membrane protein expression tool. Thus, we have made attempts to
express the cytb558 in an Escherichia coli system but the eukaryotic
Pichia pastoris expression system leads to more successful results.
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In previous studies we showed that the p13 protein coded by
human T-cell Leukemia/Lymphoma virus type-1 (HTLV-1) is targeted
to mitochondria, affects cell turnover in vitro and exerts antitumor
effects in experimental transformationmodels. The present study was
aimed at understanding the mechanism of p13 function. Assays
employing full-length synthetic p13 and isolated mitochondria
showed that p13 triggers an inward K+ current, resulting in
depolarization, increased respiratory chain activity and accumulation
of reactive oxygen species (ROS). Similar effectswere induced by the K+
ionophore valinomycin, while the protomophore FCCP reduced ROS
production, suggesting that depolarization induced by K+ vs. H+
currents has opposite effects on ROS. We next studied the effects of
p13 expression on reactive oxygen species production in HeLa and
Jurkat T-cells. Results demonstrated that p13-expressing cells exhibit
increased ROS levels and cell death. Interestingly, these effects ensued
when cells were subjected to glucose deprivation, and were abrogated
by treatment with ROS scavengers. Taken together, these ﬁndings
indicate that by remodelling mitochondrial function, p13 may control
mitochondrial ROS production and cell turnover under conditions of
metabolic stress.
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The compound miconazole is the most widely used antimycotics.
Imidazoles such as miconazole, econazole, ketoconazole and clotri-
mazole have been recently proposed to coordinate selectively
bacterial ﬂavohemoproteins thus inhibiting their oxyde nitric dioxy-
genases (NOD) activity. This enzymatic conversion thus protects
bacteria from the toxic NO and from other damaging NO-derived
